Sponsor or institution
Clinical trials and research at Jiangxi Qingfeng Pharmaceutical Co. Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Jiangxi Qingfeng Pharmaceutical Co. Ltd. that are recruiting, in China. By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Assessing GP681 for preventing influenza after exposure
This study tests if a new flu medication called GP681 can help prevent influenza in people who have been exposed to someone with the virus.
-
Evaluating GP681 tablets for high-risk influenza patients
This study tests if a new tablet called GP681 can help people aged 12 and older who are at high risk for complications from the flu feel better compared to a placebo.
Quick answers
How many clinical trials run by Jiangxi Qingfeng Pharmaceutical Co. Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.